ProShare Advisors »

Celldex Therapeutics shares owned by ProShare Advisors

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by ProShare Advisors from 13F filings

Historical chart of ProShare Advisors investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by ProShare Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by ProShare Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $469k 11k 41.97
2023-06-30 $205k 6.0k 33.93
2022-12-31 $263k 5.9k 44.57
2022-03-31 $293k 8.6k 33.96
2021-12-31 $388k 10k 38.64
2021-09-30 $318k 5.9k 53.94
2021-06-30 $340k 10k 33.43